Name |
Xianghong Liu |
Title |
Chief Pharmacist, Director of Pharmacy Department, Director of Pharmacy Intravenous Admixture Service |
Areas of Focus |
Quality control of pharmacy administration, evaluation and intervention of clinical rational drug use, traditional Chinese medicine preparation and new drug development |
Xianghong Liu is now a chief pharmacist, the director of pharmacy department and the director of pharmacy intravenous admixture service (PIVAS), master tutor, associate professor, vice director of clinical pharmacy department of pharmaceutical sciences school of Shandong University, the sixth group of national experts of traditional Chinese medicine academic experience inheritance work instructor. She has been engaged in pharmaceutical work for 38 years. She is good at quality control of pharmacy administration, evaluation and intervention of clinical rational drug use, traditional Chinese medicine preparation and new drug development. She has undertaken many national and provincial scientific research projects, published more than 20 academic papers and edited 2 books.
Professional Membership: Group leader of INRUD/China Central Group /PIVAS Rational drug Use group, standing member of the 6th Hospital Pharmacy Branch of Chinese Medicine Association, standing member of the Pharmaceutical Administration Committee of China Hospital Association, director of Shandong Pharmaceutical Administration Quality Control Center, vice president of Shandong Association of Integrative Medicine, vice secretary of Shandong Pharmaceutical Administration, The eleventh Council executive Director Shandong Pharmaceutical Administration, chairman of Hospital Pharmacy Committee of Shandong Pharmaceutical Administration, chairman of Hospital Pharmacy Committee of Shandong Association of Integrative Medicine, chairman of Professional Committee of Pharmacists' Education of Shandong Pharmacists Association. reviewer of China Journal of Hospital Pharmacy and China Pharmacy and Anhui Medical and Pharmaceutical Journal and Herald of Medicine and China Journal of Pharmaceutical Economics.